{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:31:22Z","timestamp":1792539082096,"version":"4.5.0"},"reference-count":103,"publisher":"BMJ","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the efficacy, acceptability, and safety of muscle relaxants for low back pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis of randomised controlled trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Medline, Embase, CINAHL, CENTRAL, ClinicalTrials.gov, clinicialtrialsregister.eu, and WHO ICTRP from inception to 23 February 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria for study selection<\/jats:title>\n                    <jats:p>Randomised controlled trials of muscle relaxants compared with placebo, usual care, waiting list, or no treatment in adults (\u226518 years) reporting non-specific low back pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Two reviewers independently identified studies, extracted data, and assessed the risk of bias and certainty of the evidence using the Cochrane risk-of-bias tool and Grading of Recommendations, Assessment, Development and Evaluations, respectively. Random effects meta-analytical models through restricted maximum likelihood estimation were used to estimate pooled effects and corresponding 95% confidence intervals. Outcomes included pain intensity (measured on a 0-100 point scale), disability (0-100 point scale), acceptability (discontinuation of the drug for any reason during treatment), and safety (adverse events, serious adverse events, and number of participants who withdrew from the trial because of an adverse event).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>49 trials were included in the review, of which 31, sampling 6505 participants, were quantitatively analysed. For acute low back pain, very low certainty evidence showed that at two weeks or less non-benzodiazepine antispasmodics were associated with a reduction in pain intensity compared with control (mean difference \u22127.7, 95% confidence interval\u221212.1 to\u22123.3) but not a reduction in disability (\u22123.3, \u22127.3 to 0.7). Low and very low certainty evidence showed that non-benzodiazepine antispasmodics might increase the risk of an adverse event (relative risk 1.6, 1.2 to 2.0) and might have little to no effect on acceptability (0.8, 0.6 to 1.1) compared with control for acute low back pain, respectively. The number of trials investigating other muscle relaxants and different durations of low back pain were small and the certainty of evidence was reduced because most trials were at high risk of bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Considerable uncertainty exists about the clinical efficacy and safety of muscle relaxants. Very low and low certainty evidence shows that non-benzodiazepine antispasmodics might provide small but not clinically important reductions in pain intensity at or before two weeks and might increase the risk of an adverse event in acute low back pain, respectively. Large, high quality, placebo controlled trials are urgently needed to resolve uncertainty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      PROSPERO CRD42019126820 and Open Science Framework\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/osf.io\/mu2f5\/\">https:\/\/osf.io\/mu2f5\/<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmj.n1446","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T21:25:13Z","timestamp":1625693113000},"page":"n1446","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":94,"title":["Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4190-7912","authenticated-orcid":false,"given":"Aidan G","family":"Cashin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Folly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K","family":"Bagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Wewege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley B","family":"Leake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo R N","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan M","family":"Schabrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia M","family":"Gustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0550-828X","authenticated-orcid":false,"given":"James H","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"2021070722251251000_374.jul07_12.n1446.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"2021070722251251000_374.jul07_12.n1446.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0734"},{"key":"2021070722251251000_374.jul07_12.n1446.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102013440508"},{"key":"2021070722251251000_374.jul07_12.n1446.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6748"},{"key":"2021070722251251000_374.jul07_12.n1446.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2012.00532.x"},{"key":"2021070722251251000_374.jul07_12.n1446.6","doi-asserted-by":"publisher","DOI":"10.1017\/S1463423614000140"},{"key":"2021070722251251000_374.jul07_12.n1446.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2011.03.017"},{"key":"2021070722251251000_374.jul07_12.n1446.8","unstructured":"Trevor A. Katzung BG, Knuidering-Hall M. Skeletal Muscle Relaxants. In: Katzung & Trevor\u2019s Pharmacology: Examination & Board Review. McGraw-Hill Education, 2018."},{"key":"2021070722251251000_374.jul07_12.n1446.9","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.8992"},{"key":"2021070722251251000_374.jul07_12.n1446.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-011-2135-5"},{"key":"2021070722251251000_374.jul07_12.n1446.11","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2019.1565992"},{"key":"2021070722251251000_374.jul07_12.n1446.12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7664"},{"key":"2021070722251251000_374.jul07_12.n1446.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-018-5673-2"},{"key":"2021070722251251000_374.jul07_12.n1446.14","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2367"},{"key":"2021070722251251000_374.jul07_12.n1446.15","unstructured":"Van Wambeke P, Desomer A, Ailliet L, et al. Low back pain and radicular pain: assessment and management. KCE Report 287. Belgian Health Care Knowledge Centre, 2017. https:\/\/kce.fgov.be\/sites\/default\/files\/atoms\/files\/KCE_287_Low_back_pain_Report.pdf"},{"key":"2021070722251251000_374.jul07_12.n1446.16","unstructured":"National Institute for Health and Care Excellence. Low Back Pain and Sciatica in Over 16s: Assessment and Management. NICE, 2016. https:\/\/www.nice.org.uk\/guidance\/ng59"},{"key":"2021070722251251000_374.jul07_12.n1446.17","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.907"},{"key":"2021070722251251000_374.jul07_12.n1446.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.12.006"},{"key":"2021070722251251000_374.jul07_12.n1446.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"2021070722251251000_374.jul07_12.n1446.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2021070722251251000_374.jul07_12.n1446.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"2021070722251251000_374.jul07_12.n1446.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30970-9"},{"key":"2021070722251251000_374.jul07_12.n1446.23","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index. 2020. https:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"2021070722251251000_374.jul07_12.n1446.24","unstructured":"U.S. Food and Drug Administration. Drugs@FDA. 2020. https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/drug-approvals-and-databases"},{"key":"2021070722251251000_374.jul07_12.n1446.25","unstructured":"European Medicines Agency . Medicines. 2020. https:\/\/www.ema.europa.eu\/en\/medicines"},{"key":"2021070722251251000_374.jul07_12.n1446.26","unstructured":"Australian Government Department of Health Therapeutic Goods Administration. Australian Register of Therapeutic Goods. 2020. https:\/\/www.tga.gov.au\/australian-register-therapeutic-goods"},{"key":"2021070722251251000_374.jul07_12.n1446.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39223.428495.BE"},{"key":"2021070722251251000_374.jul07_12.n1446.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-015-3892-3"},{"key":"2021070722251251000_374.jul07_12.n1446.29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210597"},{"key":"2021070722251251000_374.jul07_12.n1446.30","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.1251"},{"key":"2021070722251251000_374.jul07_12.n1446.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4825"},{"key":"2021070722251251000_374.jul07_12.n1446.32","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604"},{"key":"2021070722251251000_374.jul07_12.n1446.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"2021070722251251000_374.jul07_12.n1446.34","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000001061"},{"key":"2021070722251251000_374.jul07_12.n1446.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010919"},{"key":"2021070722251251000_374.jul07_12.n1446.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.05.006"},{"key":"2021070722251251000_374.jul07_12.n1446.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.09.005"},{"key":"2021070722251251000_374.jul07_12.n1446.38","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e31815e3a10"},{"key":"2021070722251251000_374.jul07_12.n1446.39","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141440"},{"key":"2021070722251251000_374.jul07_12.n1446.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.02.018"},{"key":"2021070722251251000_374.jul07_12.n1446.41","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2458"},{"key":"2021070722251251000_374.jul07_12.n1446.42","unstructured":"Harrer M Cuijpers P Furukawa TA . Doing meta-analysis in R: A hands-on guide. Prot Lab Erlangen, 2019."},{"key":"2021070722251251000_374.jul07_12.n1446.43","unstructured":"Prescriber\u2019s Digital Reference . PDR LLC. 2020. https:\/\/www.pdr.net"},{"key":"2021070722251251000_374.jul07_12.n1446.44","unstructured":"MIMS. Monthly Index of Medical Specialities. 2020. https:\/\/www.mims.co.uk\/"},{"key":"2021070722251251000_374.jul07_12.n1446.45","unstructured":"Australian Medicines Handbook. 2020 (online). Adelaide: Australian Medicines Handbook. 2020. https:\/\/amhonline.amh.net.au\/"},{"key":"2021070722251251000_374.jul07_12.n1446.46","first-page":"93","article-title":"Comparative efficacy of diclofenac sodium alone and in combination with thiocolchicoside in patients with low back pain","volume":"28","author":"Akhter","year":"2017","journal-title":"Med Forum"},{"key":"2021070722251251000_374.jul07_12.n1446.47","doi-asserted-by":"publisher","DOI":"10.1007\/s101950200036"},{"key":"2021070722251251000_374.jul07_12.n1446.48","doi-asserted-by":"publisher","DOI":"10.1007\/s15006-015-3307-x"},{"key":"2021070722251251000_374.jul07_12.n1446.49","first-page":"677","article-title":"A second look at skeletal muscle relaxant: a double-blind study with metaxalone","volume":"6","author":"Fathie","year":"1964","journal-title":"Curr Ther Res Clin Exp"},{"key":"2021070722251251000_374.jul07_12.n1446.50","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.10.1290"},{"key":"2021070722251251000_374.jul07_12.n1446.51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.13043"},{"key":"2021070722251251000_374.jul07_12.n1446.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2016.10.002"},{"key":"2021070722251251000_374.jul07_12.n1446.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2017.09.031"},{"key":"2021070722251251000_374.jul07_12.n1446.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2019.02.017"},{"key":"2021070722251251000_374.jul07_12.n1446.55","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.3760"},{"key":"2021070722251251000_374.jul07_12.n1446.56","first-page":"451","article-title":"Orphenadrine citrate: sedative or muscle relaxant?","volume":"1","author":"Gold","year":"1978","journal-title":"Clin Ther"},{"key":"2021070722251251000_374.jul07_12.n1446.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2004.02.214"},{"key":"2021070722251251000_374.jul07_12.n1446.58","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2016.00394.2"},{"key":"2021070722251251000_374.jul07_12.n1446.59","first-page":"7","article-title":"Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome","volume":"117","author":"Hindle","year":"1972","journal-title":"Calif Med"},{"key":"2021070722251251000_374.jul07_12.n1446.60","first-page":"303","article-title":"Diazepam in backache. A double-blind controlled trial","volume":"8","author":"Hingorani","year":"1966","journal-title":"Ann Phys Med"},{"key":"2021070722251251000_374.jul07_12.n1446.61","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.1845"},{"key":"2021070722251251000_374.jul07_12.n1446.62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2004.00454.x"},{"key":"2021070722251251000_374.jul07_12.n1446.63","first-page":"247","article-title":"Intravenous oprhenadrine for the treatment of lumbar paravertebral muscle strain","volume":"43","author":"Klinger","year":"1988","journal-title":"Curr Ther Res Clin Exp"},{"key":"2021070722251251000_374.jul07_12.n1446.64","first-page":"454","article-title":"A Comparative Trial of DS 103-282 and Placebo in the Treatment of Acute Skeletal Muscle Spasms Due to Disorders of the Back","volume":"26","author":"Lepisto","year":"1979","journal-title":"Curr Ther Res Clin Exp"},{"key":"2021070722251251000_374.jul07_12.n1446.65","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8120374"},{"key":"2021070722251251000_374.jul07_12.n1446.66","first-page":"1747","article-title":"Zur Therapie akuter lumbovertebraler Syndrome durch optimale medikament\u00f6se Muskelrelaxation mittels Diazepam","volume":"24","author":"Moll","year":"1973","journal-title":"Med Welt"},{"key":"2021070722251251000_374.jul07_12.n1446.67","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-009-1019-4"},{"key":"2021070722251251000_374.jul07_12.n1446.68","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X261014"},{"key":"2021070722251251000_374.jul07_12.n1446.69","first-page":"646","article-title":"A double-blind study of cyclobenzaprine and placebo in the treatment of acute musculoskeletal conditions of the low back","volume":"32","author":"Baratta","year":"1982","journal-title":"Curr Ther Res Clin Exp"},{"key":"2021070722251251000_374.jul07_12.n1446.70","first-page":"172","article-title":"Dantrolene sodium in low back pain and cervico brachialgia treatment: a controlled study","volume":"39","author":"Salvini","year":"1986","journal-title":"Curr Ther Res Clin Exp"},{"key":"2021070722251251000_374.jul07_12.n1446.71","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1032"},{"key":"2021070722251251000_374.jul07_12.n1446.72","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903382428"},{"key":"2021070722251251000_374.jul07_12.n1446.73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1742-1241.1976.tb05132.x","article-title":"A controlled clinical trial of a muscle relaxant analgesic combination in the treatment of acute lumbago","volume":"30","author":"Tervo","year":"1976","journal-title":"Br J Clin Pract"},{"key":"2021070722251251000_374.jul07_12.n1446.74","unstructured":"Thompson M, Kennedy G. Treatment of acute low back pain: compartive trial of two muscle relaxants, tizanidine and chlormezanone with placebo. Scandinavian Journal of Rheumatology. 2009;4-40. https:\/\/www.tandfonline.com\/doi\/abs\/10.3109\/03009748309118006"},{"key":"2021070722251251000_374.jul07_12.n1446.75","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-319X(03)00075-7"},{"key":"2021070722251251000_374.jul07_12.n1446.76","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8546-5-15"},{"key":"2021070722251251000_374.jul07_12.n1446.77","doi-asserted-by":"publisher","DOI":"10.1177\/030006058801600201"},{"key":"2021070722251251000_374.jul07_12.n1446.78","doi-asserted-by":"publisher","DOI":"10.1177\/030006058801600202"},{"key":"2021070722251251000_374.jul07_12.n1446.79","first-page":"125","article-title":"Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm","volume":"12","author":"Borenstein","year":"1990","journal-title":"Clin Ther"},{"key":"2021070722251251000_374.jul07_12.n1446.80","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-198806000-00004"},{"key":"2021070722251251000_374.jul07_12.n1446.81","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1816-6"},{"key":"2021070722251251000_374.jul07_12.n1446.82","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-198505000-00010"},{"key":"2021070722251251000_374.jul07_12.n1446.83","unstructured":"ACTRN12616000017426 . A randomised controlled feasibility study of managing sleep with Zopiclone in participants with acute low back pain and sleep disturbances. Australia New Zealand Clinical Trials Registry, 2016."},{"key":"2021070722251251000_374.jul07_12.n1446.84","unstructured":"EUCTR2017-004530-29. No Title. Clinicaltrialsregister.eu. 2017."},{"key":"2021070722251251000_374.jul07_12.n1446.85","unstructured":"NCT02887534. Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain. ClinicalTrials.gov. 2016."},{"key":"2021070722251251000_374.jul07_12.n1446.86","unstructured":"NCT01587508. Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago. ClinicalTrials.gov. 2012."},{"key":"2021070722251251000_374.jul07_12.n1446.87","unstructured":"EUCTR2019-001885-14. No Title. Clinicaltrialsregister.eu. 2019."},{"key":"2021070722251251000_374.jul07_12.n1446.88","unstructured":"IRCT20111109008035N4. The study of efficacy of melatonin, and zolpidem on the sleep quality, and severity of pain in the patients with chronic non-specific low back pain. ISRCTN. 2017."},{"key":"2021070722251251000_374.jul07_12.n1446.89","unstructured":"NCT00671879. Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back. ClinicalTrials.gov. 2008."},{"key":"2021070722251251000_374.jul07_12.n1446.90","unstructured":"NCT00671502. A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back. ClinicalTrials.gov. 2008."},{"key":"2021070722251251000_374.jul07_12.n1446.91","unstructured":"NCT00817986. A Study to Evaluate the Safety and Tolerability of Arbaclofen Placarbil (XP19986) in Subjects With Acute Back Spasms. ClinicalTrials.gov. 2009."},{"key":"2021070722251251000_374.jul07_12.n1446.92","unstructured":"NCT00404417. Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain. ClinicalTrials.gov. 2006."},{"key":"2021070722251251000_374.jul07_12.n1446.93","unstructured":"NCT00384579. Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain. ClinicalTrials.gov. 2006."},{"key":"2021070722251251000_374.jul07_12.n1446.94","unstructured":"NCT00384371. Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain. ClinicalTrials.gov. 2006."},{"key":"2021070722251251000_374.jul07_12.n1446.95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004252"},{"key":"2021070722251251000_374.jul07_12.n1446.96","doi-asserted-by":"publisher","DOI":"10.5324\/nje.v18i2.29"},{"key":"2021070722251251000_374.jul07_12.n1446.97","unstructured":"Medicines and Health products Regulatory Agency. Carisoprodol and meprobamate: risks outweigh benefits. GOV.UK. 2014. https:\/\/www.gov.uk\/drug-safety-update\/carisoprodol-and-meprobamate-risks-outweigh-benefits"},{"key":"2021070722251251000_374.jul07_12.n1446.98","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n80"},{"key":"2021070722251251000_374.jul07_12.n1446.99","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a171"},{"key":"2021070722251251000_374.jul07_12.n1446.100","first-page":"427","article-title":"Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain","volume":"39","author":"Witenko","year":"2014","journal-title":"P T"},{"key":"2021070722251251000_374.jul07_12.n1446.101","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-015-3892-3"},{"key":"2021070722251251000_374.jul07_12.n1446.102","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.09.012"},{"key":"2021070722251251000_374.jul07_12.n1446.103","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c332"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.n1446","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.n1446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T15:04:30Z","timestamp":1699196670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.n1446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":103,"alternative-id":["10.1136\/bmj.n1446"],"URL":"https:\/\/doi.org\/10.1136\/bmj.n1446","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]}}}